Antiphospholipid syndrome (APS) is a rare autoimmune disease of unknown etiology that
represents a leading cause of acquired thromboembolism and recurrent miscarriage. It is …

Primary antiphospholipid syndrome (PAPS) and antiphospholipid syndrome associated to
lupus (SAPS) have several overlapping characteristics. As systemic manifestations are also …

The aim of this study was to evaluate oxidative stress markers and it relations to endothelial
damage as risk factor for thrombosis in patients with primary (PAPS) and secondary (SAPS) …

Are the cutaneous manifestations in patients with primary antiphospholipid syndrome a marker
for predicting lung manifestations? Page 1 Are the cutaneous manifestations in patients with …

Objectives Antiphospholipid syndrome (APS) is multisystem autoimmune coagulopathy with
antiphospholipid antibodies (aPL) in its ground, manifested as a primary disease (PAPS) or …

Catastrophic antiphospholipid syndrome (CAPS) is a severe variant of APS, characterised
by clinical evidence of multiple organ involvement developing over a very short period of …

Objective: The potential contribution of asymmetric dimethylarginine (ADMA) and high-
sensitivity C reactive protein (hsCRP) to endothelial dysfunction in APS patients has not …

A 26 year old female presented for recurrent blood tinged sputum during the previous year
with development of frank hemoptysis three days prior to admission. Diffuse alveolar …

Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by
recurrent thromboembolic events (arterial or venous) and/or morbidity in pregnancy (fetal …

Background Antiphospholipid syndrome (APS) is characterized by antiphospholipid
antibodies (aPLs) associated with thrombosis (arterial and/or venous) and/or obstetrical …